Form 4: Hologic CFO Karleen Marie Oberton Reports Acquisition of Common Stock

Chief Financial Officer of Hologic, Karleen Marie Oberton, reports acquiring 23,710 shares of common stock on November 5, 2024, bringing her total holdings to 107,752 shares.

Summary

• Karleen Marie Oberton, the Chief Financial Officer of Hologic Inc., filed a Form 4 on November 7, 2024.
• The report details a transaction on November 5, 2024, where Oberton acquired 23,710 shares of Hologic's common stock.
• This acquisition increased her total beneficial ownership to 107,752 shares.
• The acquired shares include performance stock units that have met performance criteria but are still subject to service-based vesting.
• The performance stock units are settled in shares of common stock on a one-for-one basis.
• Oberton's holdings also include 41,121 restricted stock units/performance stock units with deferred settlement under Hologic's Deferred Equity Plan.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, and the sentiment is neutral. It simply reports a transaction.

Positives

• The acquisition of shares by a high-ranking officer could be interpreted positively by investors.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.

Stakeholder Impact

• The transaction could influence investor perception of the company.

Key Dates